nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—Epirubicin—pancreatic cancer	0.152	0.519	CrCtD
Idarubicin—Doxorubicin—pancreatic cancer	0.14	0.481	CrCtD
Idarubicin—Anthracyclines—Epirubicin—pancreatic cancer	0.097	0.256	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Irinotecan—pancreatic cancer	0.0939	0.248	CiPCiCtD
Idarubicin—Anthracyclines—Doxorubicin—pancreatic cancer	0.0898	0.237	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Epirubicin—pancreatic cancer	0.0507	0.134	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Doxorubicin—pancreatic cancer	0.0469	0.124	CiPCiCtD
Idarubicin—Valrubicin—Epirubicin—pancreatic cancer	0.0324	0.173	CrCrCtD
Idarubicin—Daunorubicin—Epirubicin—pancreatic cancer	0.0324	0.173	CrCrCtD
Idarubicin—Doxorubicin—Epirubicin—pancreatic cancer	0.0324	0.173	CrCrCtD
Idarubicin—Valrubicin—Doxorubicin—pancreatic cancer	0.03	0.16	CrCrCtD
Idarubicin—Epirubicin—Doxorubicin—pancreatic cancer	0.03	0.16	CrCrCtD
Idarubicin—Daunorubicin—Doxorubicin—pancreatic cancer	0.03	0.16	CrCrCtD
Idarubicin—TOP2A—Epirubicin—pancreatic cancer	0.0256	0.251	CbGbCtD
Idarubicin—ABCC1—Epirubicin—pancreatic cancer	0.0142	0.139	CbGbCtD
Idarubicin—ABCC1—Irinotecan—pancreatic cancer	0.0138	0.135	CbGbCtD
Idarubicin—TOP2A—Doxorubicin—pancreatic cancer	0.0136	0.133	CbGbCtD
Idarubicin—ABCC1—Docetaxel—pancreatic cancer	0.0101	0.0993	CbGbCtD
Idarubicin—ABCC1—Doxorubicin—pancreatic cancer	0.00755	0.074	CbGbCtD
Idarubicin—CYP2C9—Tamoxifen—pancreatic cancer	0.00448	0.0439	CbGbCtD
Idarubicin—CYP2D6—Tamoxifen—pancreatic cancer	0.00409	0.0401	CbGbCtD
Idarubicin—CYP2D6—Erlotinib—pancreatic cancer	0.00348	0.0341	CbGbCtD
Idarubicin—CYP2C9—Fluorouracil—pancreatic cancer	0.0033	0.0323	CbGbCtD
Idarubicin—CYP2D6—Doxorubicin—pancreatic cancer	0.00172	0.0168	CbGbCtD
Idarubicin—TOP2A—Topotecan—Irinotecan—pancreatic cancer	0.000204	0.269	CbGdCrCtD
Idarubicin—TOP2A—Paclitaxel—Docetaxel—pancreatic cancer	0.000143	0.189	CbGdCrCtD
Idarubicin—TOP2A—Gefitinib—Erlotinib—pancreatic cancer	0.000137	0.181	CbGdCrCtD
Idarubicin—TOP2A—Cytarabine—Gemcitabine—pancreatic cancer	5.18e-05	0.0682	CbGdCrCtD
Idarubicin—TOP2A—Doxorubicin—Epirubicin—pancreatic cancer	4.8e-05	0.0633	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Epirubicin—pancreatic cancer	4.8e-05	0.0633	CbGdCrCtD
Idarubicin—TOP2A—Epirubicin—Doxorubicin—pancreatic cancer	4.44e-05	0.0585	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Doxorubicin—pancreatic cancer	4.44e-05	0.0585	CbGdCrCtD
Idarubicin—Atrioventricular block—Epirubicin—pancreatic cancer	4.38e-05	0.00112	CcSEcCtD
Idarubicin—Urethral disorder—Gemcitabine—pancreatic cancer	4.37e-05	0.00112	CcSEcCtD
Idarubicin—Anorexia—Erlotinib—pancreatic cancer	4.35e-05	0.00111	CcSEcCtD
Idarubicin—Leukopenia—Sunitinib—pancreatic cancer	4.33e-05	0.0011	CcSEcCtD
Idarubicin—Blood uric acid increased—Epirubicin—pancreatic cancer	4.33e-05	0.0011	CcSEcCtD
Idarubicin—Dehydration—Docetaxel—pancreatic cancer	4.25e-05	0.00109	CcSEcCtD
Idarubicin—Flushing—Irinotecan—pancreatic cancer	4.25e-05	0.00108	CcSEcCtD
Idarubicin—Hyperuricaemia—Doxorubicin—pancreatic cancer	4.24e-05	0.00108	CcSEcCtD
Idarubicin—Convulsion—Sunitinib—pancreatic cancer	4.19e-05	0.00107	CcSEcCtD
Idarubicin—Ulcer—Doxorubicin—pancreatic cancer	4.16e-05	0.00106	CcSEcCtD
Idarubicin—Angiopathy—Irinotecan—pancreatic cancer	4.15e-05	0.00106	CcSEcCtD
Idarubicin—Immune system disorder—Irinotecan—pancreatic cancer	4.13e-05	0.00105	CcSEcCtD
Idarubicin—Chest pain—Sunitinib—pancreatic cancer	4.12e-05	0.00105	CcSEcCtD
Idarubicin—Chills—Irinotecan—pancreatic cancer	4.11e-05	0.00105	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	4.09e-05	0.00104	CcSEcCtD
Idarubicin—Arrhythmia—Irinotecan—pancreatic cancer	4.09e-05	0.00104	CcSEcCtD
Idarubicin—Colitis—Epirubicin—pancreatic cancer	4.08e-05	0.00104	CcSEcCtD
Idarubicin—Atrioventricular block—Doxorubicin—pancreatic cancer	4.05e-05	0.00103	CcSEcCtD
Idarubicin—Angiopathy—Gemcitabine—pancreatic cancer	4.05e-05	0.00103	CcSEcCtD
Idarubicin—Alopecia—Irinotecan—pancreatic cancer	4.05e-05	0.00103	CcSEcCtD
Idarubicin—Immune system disorder—Gemcitabine—pancreatic cancer	4.03e-05	0.00103	CcSEcCtD
Idarubicin—Decreased appetite—Tamoxifen—pancreatic cancer	4.01e-05	0.00102	CcSEcCtD
Idarubicin—Blood uric acid increased—Doxorubicin—pancreatic cancer	4e-05	0.00102	CcSEcCtD
Idarubicin—Chills—Gemcitabine—pancreatic cancer	4e-05	0.00102	CcSEcCtD
Idarubicin—Arrhythmia—Gemcitabine—pancreatic cancer	3.98e-05	0.00102	CcSEcCtD
Idarubicin—Decreased appetite—Erlotinib—pancreatic cancer	3.96e-05	0.00101	CcSEcCtD
Idarubicin—Alopecia—Gemcitabine—pancreatic cancer	3.94e-05	0.00101	CcSEcCtD
Idarubicin—Infection—Sunitinib—pancreatic cancer	3.92e-05	0.001	CcSEcCtD
Idarubicin—Arrhythmia—Fluorouracil—pancreatic cancer	3.92e-05	0.000999	CcSEcCtD
Idarubicin—Shock—Sunitinib—pancreatic cancer	3.88e-05	0.000991	CcSEcCtD
Idarubicin—Oesophagitis—Epirubicin—pancreatic cancer	3.88e-05	0.000991	CcSEcCtD
Idarubicin—Alopecia—Fluorouracil—pancreatic cancer	3.87e-05	0.000988	CcSEcCtD
Idarubicin—Thrombocytopenia—Sunitinib—pancreatic cancer	3.87e-05	0.000986	CcSEcCtD
Idarubicin—Neoplasm—Epirubicin—pancreatic cancer	3.84e-05	0.00098	CcSEcCtD
Idarubicin—Skin disorder—Sunitinib—pancreatic cancer	3.84e-05	0.000978	CcSEcCtD
Idarubicin—Colitis—Doxorubicin—pancreatic cancer	3.78e-05	0.000963	CcSEcCtD
Idarubicin—Gastrointestinal pain—Tamoxifen—pancreatic cancer	3.77e-05	0.000962	CcSEcCtD
Idarubicin—Anorexia—Sunitinib—pancreatic cancer	3.76e-05	0.00096	CcSEcCtD
Idarubicin—Pancytopenia—Docetaxel—pancreatic cancer	3.75e-05	0.000958	CcSEcCtD
Idarubicin—Gastrointestinal pain—Erlotinib—pancreatic cancer	3.73e-05	0.000952	CcSEcCtD
Idarubicin—TOP2A—Azacitidine—Gemcitabine—pancreatic cancer	3.71e-05	0.0489	CbGdCrCtD
Idarubicin—Neutropenia—Docetaxel—pancreatic cancer	3.7e-05	0.000943	CcSEcCtD
Idarubicin—Sepsis—Epirubicin—pancreatic cancer	3.69e-05	0.000941	CcSEcCtD
Idarubicin—Anaemia—Irinotecan—pancreatic cancer	3.68e-05	0.00094	CcSEcCtD
Idarubicin—Urticaria—Tamoxifen—pancreatic cancer	3.66e-05	0.000934	CcSEcCtD
Idarubicin—Abdominal pain—Tamoxifen—pancreatic cancer	3.64e-05	0.00093	CcSEcCtD
Idarubicin—Abdominal pain—Erlotinib—pancreatic cancer	3.61e-05	0.00092	CcSEcCtD
Idarubicin—Body temperature increased—Erlotinib—pancreatic cancer	3.61e-05	0.00092	CcSEcCtD
Idarubicin—Oesophagitis—Doxorubicin—pancreatic cancer	3.59e-05	0.000917	CcSEcCtD
Idarubicin—Anaemia—Gemcitabine—pancreatic cancer	3.59e-05	0.000915	CcSEcCtD
Idarubicin—Phlebitis—Epirubicin—pancreatic cancer	3.58e-05	0.000914	CcSEcCtD
Idarubicin—Leukopenia—Irinotecan—pancreatic cancer	3.57e-05	0.00091	CcSEcCtD
Idarubicin—Thrombophlebitis—Epirubicin—pancreatic cancer	3.56e-05	0.000909	CcSEcCtD
Idarubicin—Neoplasm—Doxorubicin—pancreatic cancer	3.56e-05	0.000907	CcSEcCtD
Idarubicin—Hepatic function abnormal—Epirubicin—pancreatic cancer	3.53e-05	0.000901	CcSEcCtD
Idarubicin—Anaemia—Fluorouracil—pancreatic cancer	3.53e-05	0.0009	CcSEcCtD
Idarubicin—Acute coronary syndrome—Docetaxel—pancreatic cancer	3.47e-05	0.000887	CcSEcCtD
Idarubicin—Leukopenia—Gemcitabine—pancreatic cancer	3.47e-05	0.000887	CcSEcCtD
Idarubicin—Myocardial infarction—Docetaxel—pancreatic cancer	3.46e-05	0.000882	CcSEcCtD
Idarubicin—Stomatitis—Docetaxel—pancreatic cancer	3.44e-05	0.000877	CcSEcCtD
Idarubicin—Decreased appetite—Sunitinib—pancreatic cancer	3.43e-05	0.000876	CcSEcCtD
Idarubicin—Leukopenia—Fluorouracil—pancreatic cancer	3.42e-05	0.000872	CcSEcCtD
Idarubicin—Sepsis—Doxorubicin—pancreatic cancer	3.41e-05	0.000871	CcSEcCtD
Idarubicin—Cardiac failure congestive—Epirubicin—pancreatic cancer	3.4e-05	0.000868	CcSEcCtD
Idarubicin—Hypersensitivity—Tamoxifen—pancreatic cancer	3.4e-05	0.000867	CcSEcCtD
Idarubicin—Phlebitis—Doxorubicin—pancreatic cancer	3.31e-05	0.000845	CcSEcCtD
Idarubicin—Convulsion—Fluorouracil—pancreatic cancer	3.31e-05	0.000844	CcSEcCtD
Idarubicin—Chest pain—Gemcitabine—pancreatic cancer	3.3e-05	0.000843	CcSEcCtD
Idarubicin—Hot flush—Epirubicin—pancreatic cancer	3.3e-05	0.000841	CcSEcCtD
Idarubicin—Thrombophlebitis—Doxorubicin—pancreatic cancer	3.3e-05	0.000841	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	3.28e-05	0.000837	CcSEcCtD
Idarubicin—Menopausal symptoms—Epirubicin—pancreatic cancer	3.27e-05	0.000834	CcSEcCtD
Idarubicin—Hepatic function abnormal—Doxorubicin—pancreatic cancer	3.27e-05	0.000833	CcSEcCtD
Idarubicin—Anaphylactic shock—Irinotecan—pancreatic cancer	3.25e-05	0.00083	CcSEcCtD
Idarubicin—Chest pain—Fluorouracil—pancreatic cancer	3.25e-05	0.000829	CcSEcCtD
Idarubicin—Infection—Irinotecan—pancreatic cancer	3.23e-05	0.000824	CcSEcCtD
Idarubicin—Gastrointestinal pain—Sunitinib—pancreatic cancer	3.23e-05	0.000824	CcSEcCtD
Idarubicin—Shock—Irinotecan—pancreatic cancer	3.2e-05	0.000816	CcSEcCtD
Idarubicin—Thrombocytopenia—Irinotecan—pancreatic cancer	3.18e-05	0.000812	CcSEcCtD
Idarubicin—Haemoglobin—Docetaxel—pancreatic cancer	3.18e-05	0.000811	CcSEcCtD
Idarubicin—Anaphylactic shock—Gemcitabine—pancreatic cancer	3.17e-05	0.000808	CcSEcCtD
Idarubicin—Haemorrhage—Docetaxel—pancreatic cancer	3.16e-05	0.000807	CcSEcCtD
Idarubicin—Diarrhoea—Tamoxifen—pancreatic cancer	3.15e-05	0.000805	CcSEcCtD
Idarubicin—Cardiac failure congestive—Doxorubicin—pancreatic cancer	3.15e-05	0.000803	CcSEcCtD
Idarubicin—Infection—Gemcitabine—pancreatic cancer	3.15e-05	0.000803	CcSEcCtD
Idarubicin—Urinary tract disorder—Docetaxel—pancreatic cancer	3.13e-05	0.000797	CcSEcCtD
Idarubicin—Body temperature increased—Sunitinib—pancreatic cancer	3.12e-05	0.000796	CcSEcCtD
Idarubicin—Abdominal pain—Sunitinib—pancreatic cancer	3.12e-05	0.000796	CcSEcCtD
Idarubicin—Diarrhoea—Erlotinib—pancreatic cancer	3.12e-05	0.000796	CcSEcCtD
Idarubicin—Anaphylactic shock—Fluorouracil—pancreatic cancer	3.11e-05	0.000795	CcSEcCtD
Idarubicin—Urethral disorder—Docetaxel—pancreatic cancer	3.1e-05	0.000791	CcSEcCtD
Idarubicin—Thrombocytopenia—Gemcitabine—pancreatic cancer	3.1e-05	0.000791	CcSEcCtD
Idarubicin—Anorexia—Irinotecan—pancreatic cancer	3.1e-05	0.000791	CcSEcCtD
Idarubicin—Infection—Fluorouracil—pancreatic cancer	3.09e-05	0.00079	CcSEcCtD
Idarubicin—Skin disorder—Gemcitabine—pancreatic cancer	3.08e-05	0.000785	CcSEcCtD
Idarubicin—Hot flush—Doxorubicin—pancreatic cancer	3.05e-05	0.000779	CcSEcCtD
Idarubicin—Thrombocytopenia—Fluorouracil—pancreatic cancer	3.05e-05	0.000778	CcSEcCtD
Idarubicin—Menopausal symptoms—Doxorubicin—pancreatic cancer	3.03e-05	0.000772	CcSEcCtD
Idarubicin—Anorexia—Gemcitabine—pancreatic cancer	3.02e-05	0.00077	CcSEcCtD
Idarubicin—Anorexia—Fluorouracil—pancreatic cancer	2.97e-05	0.000758	CcSEcCtD
Idarubicin—Flushing—Docetaxel—pancreatic cancer	2.94e-05	0.000749	CcSEcCtD
Idarubicin—Vomiting—Tamoxifen—pancreatic cancer	2.93e-05	0.000748	CcSEcCtD
Idarubicin—Hypersensitivity—Sunitinib—pancreatic cancer	2.91e-05	0.000742	CcSEcCtD
Idarubicin—Rash—Tamoxifen—pancreatic cancer	2.91e-05	0.000742	CcSEcCtD
Idarubicin—Dermatitis—Tamoxifen—pancreatic cancer	2.9e-05	0.000741	CcSEcCtD
Idarubicin—Vomiting—Erlotinib—pancreatic cancer	2.9e-05	0.00074	CcSEcCtD
Idarubicin—Headache—Tamoxifen—pancreatic cancer	2.89e-05	0.000737	CcSEcCtD
Idarubicin—Rash—Erlotinib—pancreatic cancer	2.88e-05	0.000734	CcSEcCtD
Idarubicin—Dermatitis—Erlotinib—pancreatic cancer	2.87e-05	0.000733	CcSEcCtD
Idarubicin—Angiopathy—Docetaxel—pancreatic cancer	2.87e-05	0.000733	CcSEcCtD
Idarubicin—Dehydration—Epirubicin—pancreatic cancer	2.87e-05	0.000732	CcSEcCtD
Idarubicin—Immune system disorder—Docetaxel—pancreatic cancer	2.86e-05	0.000729	CcSEcCtD
Idarubicin—Headache—Erlotinib—pancreatic cancer	2.86e-05	0.000729	CcSEcCtD
Idarubicin—Chills—Docetaxel—pancreatic cancer	2.84e-05	0.000724	CcSEcCtD
Idarubicin—Decreased appetite—Irinotecan—pancreatic cancer	2.83e-05	0.000721	CcSEcCtD
Idarubicin—Arrhythmia—Docetaxel—pancreatic cancer	2.83e-05	0.000721	CcSEcCtD
Idarubicin—Alopecia—Docetaxel—pancreatic cancer	2.8e-05	0.000713	CcSEcCtD
Idarubicin—Malnutrition—Docetaxel—pancreatic cancer	2.75e-05	0.000703	CcSEcCtD
Idarubicin—Decreased appetite—Gemcitabine—pancreatic cancer	2.75e-05	0.000703	CcSEcCtD
Idarubicin—Nausea—Tamoxifen—pancreatic cancer	2.74e-05	0.000699	CcSEcCtD
Idarubicin—Nausea—Erlotinib—pancreatic cancer	2.71e-05	0.000691	CcSEcCtD
Idarubicin—Decreased appetite—Fluorouracil—pancreatic cancer	2.71e-05	0.000691	CcSEcCtD
Idarubicin—Diarrhoea—Sunitinib—pancreatic cancer	2.7e-05	0.000689	CcSEcCtD
Idarubicin—Gastrointestinal pain—Irinotecan—pancreatic cancer	2.66e-05	0.000679	CcSEcCtD
Idarubicin—Dehydration—Doxorubicin—pancreatic cancer	2.65e-05	0.000677	CcSEcCtD
Idarubicin—Body temperature increased—Irinotecan—pancreatic cancer	2.57e-05	0.000656	CcSEcCtD
Idarubicin—Abdominal pain—Irinotecan—pancreatic cancer	2.57e-05	0.000656	CcSEcCtD
Idarubicin—Anaemia—Docetaxel—pancreatic cancer	2.55e-05	0.00065	CcSEcCtD
Idarubicin—Pancytopenia—Epirubicin—pancreatic cancer	2.53e-05	0.000646	CcSEcCtD
Idarubicin—Vomiting—Sunitinib—pancreatic cancer	2.51e-05	0.00064	CcSEcCtD
Idarubicin—Body temperature increased—Gemcitabine—pancreatic cancer	2.5e-05	0.000639	CcSEcCtD
Idarubicin—Neutropenia—Epirubicin—pancreatic cancer	2.49e-05	0.000636	CcSEcCtD
Idarubicin—Rash—Sunitinib—pancreatic cancer	2.49e-05	0.000635	CcSEcCtD
Idarubicin—Dermatitis—Sunitinib—pancreatic cancer	2.49e-05	0.000635	CcSEcCtD
Idarubicin—Urticaria—Fluorouracil—pancreatic cancer	2.47e-05	0.000631	CcSEcCtD
Idarubicin—Headache—Sunitinib—pancreatic cancer	2.47e-05	0.000631	CcSEcCtD
Idarubicin—Leukopenia—Docetaxel—pancreatic cancer	2.47e-05	0.000629	CcSEcCtD
Idarubicin—Body temperature increased—Fluorouracil—pancreatic cancer	2.46e-05	0.000628	CcSEcCtD
Idarubicin—Hypersensitivity—Irinotecan—pancreatic cancer	2.4e-05	0.000611	CcSEcCtD
Idarubicin—Convulsion—Docetaxel—pancreatic cancer	2.39e-05	0.000609	CcSEcCtD
Idarubicin—Chest pain—Docetaxel—pancreatic cancer	2.35e-05	0.000598	CcSEcCtD
Idarubicin—Nausea—Sunitinib—pancreatic cancer	2.35e-05	0.000598	CcSEcCtD
Idarubicin—Pancytopenia—Doxorubicin—pancreatic cancer	2.34e-05	0.000598	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	2.33e-05	0.000594	CcSEcCtD
Idarubicin—Stomatitis—Epirubicin—pancreatic cancer	2.32e-05	0.000591	CcSEcCtD
Idarubicin—Neutropenia—Doxorubicin—pancreatic cancer	2.31e-05	0.000589	CcSEcCtD
Idarubicin—Hypersensitivity—Fluorouracil—pancreatic cancer	2.29e-05	0.000586	CcSEcCtD
Idarubicin—Anaphylactic shock—Docetaxel—pancreatic cancer	2.25e-05	0.000574	CcSEcCtD
Idarubicin—Infection—Docetaxel—pancreatic cancer	2.23e-05	0.00057	CcSEcCtD
Idarubicin—Diarrhoea—Irinotecan—pancreatic cancer	2.23e-05	0.000568	CcSEcCtD
Idarubicin—Shock—Docetaxel—pancreatic cancer	2.21e-05	0.000564	CcSEcCtD
Idarubicin—Thrombocytopenia—Docetaxel—pancreatic cancer	2.2e-05	0.000562	CcSEcCtD
Idarubicin—Skin disorder—Docetaxel—pancreatic cancer	2.18e-05	0.000557	CcSEcCtD
Idarubicin—Diarrhoea—Gemcitabine—pancreatic cancer	2.17e-05	0.000553	CcSEcCtD
Idarubicin—Haemoglobin—Epirubicin—pancreatic cancer	2.15e-05	0.000547	CcSEcCtD
Idarubicin—Stomatitis—Doxorubicin—pancreatic cancer	2.14e-05	0.000547	CcSEcCtD
Idarubicin—Anorexia—Docetaxel—pancreatic cancer	2.14e-05	0.000547	CcSEcCtD
Idarubicin—Haemorrhage—Epirubicin—pancreatic cancer	2.13e-05	0.000545	CcSEcCtD
Idarubicin—Diarrhoea—Fluorouracil—pancreatic cancer	2.13e-05	0.000544	CcSEcCtD
Idarubicin—Urinary tract disorder—Epirubicin—pancreatic cancer	2.11e-05	0.000538	CcSEcCtD
Idarubicin—Urethral disorder—Epirubicin—pancreatic cancer	2.09e-05	0.000534	CcSEcCtD
Idarubicin—Vomiting—Irinotecan—pancreatic cancer	2.07e-05	0.000528	CcSEcCtD
Idarubicin—Rash—Irinotecan—pancreatic cancer	2.05e-05	0.000523	CcSEcCtD
Idarubicin—Dermatitis—Irinotecan—pancreatic cancer	2.05e-05	0.000523	CcSEcCtD
Idarubicin—Headache—Irinotecan—pancreatic cancer	2.04e-05	0.00052	CcSEcCtD
Idarubicin—Vomiting—Gemcitabine—pancreatic cancer	2.01e-05	0.000514	CcSEcCtD
Idarubicin—Rash—Gemcitabine—pancreatic cancer	2e-05	0.00051	CcSEcCtD
Idarubicin—Dermatitis—Gemcitabine—pancreatic cancer	2e-05	0.000509	CcSEcCtD
Idarubicin—Haemoglobin—Doxorubicin—pancreatic cancer	1.98e-05	0.000506	CcSEcCtD
Idarubicin—Headache—Gemcitabine—pancreatic cancer	1.98e-05	0.000506	CcSEcCtD
Idarubicin—Flushing—Epirubicin—pancreatic cancer	1.98e-05	0.000505	CcSEcCtD
Idarubicin—Vomiting—Fluorouracil—pancreatic cancer	1.98e-05	0.000505	CcSEcCtD
Idarubicin—Haemorrhage—Doxorubicin—pancreatic cancer	1.97e-05	0.000504	CcSEcCtD
Idarubicin—Rash—Fluorouracil—pancreatic cancer	1.96e-05	0.000501	CcSEcCtD
Idarubicin—Dermatitis—Fluorouracil—pancreatic cancer	1.96e-05	0.000501	CcSEcCtD
Idarubicin—Decreased appetite—Docetaxel—pancreatic cancer	1.95e-05	0.000499	CcSEcCtD
Idarubicin—Headache—Fluorouracil—pancreatic cancer	1.95e-05	0.000498	CcSEcCtD
Idarubicin—Urinary tract disorder—Doxorubicin—pancreatic cancer	1.95e-05	0.000498	CcSEcCtD
Idarubicin—Angiopathy—Epirubicin—pancreatic cancer	1.94e-05	0.000494	CcSEcCtD
Idarubicin—Urethral disorder—Doxorubicin—pancreatic cancer	1.94e-05	0.000494	CcSEcCtD
Idarubicin—Nausea—Irinotecan—pancreatic cancer	1.93e-05	0.000493	CcSEcCtD
Idarubicin—Immune system disorder—Epirubicin—pancreatic cancer	1.93e-05	0.000492	CcSEcCtD
Idarubicin—Chills—Epirubicin—pancreatic cancer	1.92e-05	0.000489	CcSEcCtD
Idarubicin—Arrhythmia—Epirubicin—pancreatic cancer	1.91e-05	0.000486	CcSEcCtD
Idarubicin—Alopecia—Epirubicin—pancreatic cancer	1.89e-05	0.000481	CcSEcCtD
Idarubicin—Nausea—Gemcitabine—pancreatic cancer	1.88e-05	0.00048	CcSEcCtD
Idarubicin—Malnutrition—Epirubicin—pancreatic cancer	1.86e-05	0.000474	CcSEcCtD
Idarubicin—Nausea—Fluorouracil—pancreatic cancer	1.85e-05	0.000472	CcSEcCtD
Idarubicin—Gastrointestinal pain—Docetaxel—pancreatic cancer	1.84e-05	0.000469	CcSEcCtD
Idarubicin—Flushing—Doxorubicin—pancreatic cancer	1.83e-05	0.000468	CcSEcCtD
Idarubicin—Angiopathy—Doxorubicin—pancreatic cancer	1.79e-05	0.000457	CcSEcCtD
Idarubicin—Immune system disorder—Doxorubicin—pancreatic cancer	1.78e-05	0.000455	CcSEcCtD
Idarubicin—Abdominal pain—Docetaxel—pancreatic cancer	1.78e-05	0.000453	CcSEcCtD
Idarubicin—Body temperature increased—Docetaxel—pancreatic cancer	1.78e-05	0.000453	CcSEcCtD
Idarubicin—Chills—Doxorubicin—pancreatic cancer	1.77e-05	0.000452	CcSEcCtD
Idarubicin—Arrhythmia—Doxorubicin—pancreatic cancer	1.76e-05	0.00045	CcSEcCtD
Idarubicin—Alopecia—Doxorubicin—pancreatic cancer	1.75e-05	0.000445	CcSEcCtD
Idarubicin—Malnutrition—Doxorubicin—pancreatic cancer	1.72e-05	0.000439	CcSEcCtD
Idarubicin—Anaemia—Epirubicin—pancreatic cancer	1.72e-05	0.000438	CcSEcCtD
Idarubicin—Leukopenia—Epirubicin—pancreatic cancer	1.66e-05	0.000424	CcSEcCtD
Idarubicin—Hypersensitivity—Docetaxel—pancreatic cancer	1.66e-05	0.000423	CcSEcCtD
Idarubicin—Convulsion—Epirubicin—pancreatic cancer	1.61e-05	0.000411	CcSEcCtD
Idarubicin—Anaemia—Doxorubicin—pancreatic cancer	1.59e-05	0.000405	CcSEcCtD
Idarubicin—Chest pain—Epirubicin—pancreatic cancer	1.58e-05	0.000404	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	1.57e-05	0.000401	CcSEcCtD
Idarubicin—Leukopenia—Doxorubicin—pancreatic cancer	1.54e-05	0.000393	CcSEcCtD
Idarubicin—Diarrhoea—Docetaxel—pancreatic cancer	1.54e-05	0.000392	CcSEcCtD
Idarubicin—Anaphylactic shock—Epirubicin—pancreatic cancer	1.52e-05	0.000387	CcSEcCtD
Idarubicin—Infection—Epirubicin—pancreatic cancer	1.51e-05	0.000384	CcSEcCtD
Idarubicin—Shock—Epirubicin—pancreatic cancer	1.49e-05	0.000381	CcSEcCtD
Idarubicin—Convulsion—Doxorubicin—pancreatic cancer	1.49e-05	0.00038	CcSEcCtD
Idarubicin—Thrombocytopenia—Epirubicin—pancreatic cancer	1.48e-05	0.000379	CcSEcCtD
Idarubicin—Skin disorder—Epirubicin—pancreatic cancer	1.47e-05	0.000376	CcSEcCtD
Idarubicin—Chest pain—Doxorubicin—pancreatic cancer	1.46e-05	0.000373	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	1.45e-05	0.000371	CcSEcCtD
Idarubicin—Anorexia—Epirubicin—pancreatic cancer	1.45e-05	0.000369	CcSEcCtD
Idarubicin—Vomiting—Docetaxel—pancreatic cancer	1.43e-05	0.000365	CcSEcCtD
Idarubicin—Rash—Docetaxel—pancreatic cancer	1.42e-05	0.000362	CcSEcCtD
Idarubicin—Dermatitis—Docetaxel—pancreatic cancer	1.42e-05	0.000361	CcSEcCtD
Idarubicin—Headache—Docetaxel—pancreatic cancer	1.41e-05	0.000359	CcSEcCtD
Idarubicin—Anaphylactic shock—Doxorubicin—pancreatic cancer	1.4e-05	0.000358	CcSEcCtD
Idarubicin—Infection—Doxorubicin—pancreatic cancer	1.39e-05	0.000356	CcSEcCtD
Idarubicin—Shock—Doxorubicin—pancreatic cancer	1.38e-05	0.000352	CcSEcCtD
Idarubicin—Thrombocytopenia—Doxorubicin—pancreatic cancer	1.37e-05	0.000351	CcSEcCtD
Idarubicin—Skin disorder—Doxorubicin—pancreatic cancer	1.36e-05	0.000348	CcSEcCtD
Idarubicin—Anorexia—Doxorubicin—pancreatic cancer	1.34e-05	0.000341	CcSEcCtD
Idarubicin—Nausea—Docetaxel—pancreatic cancer	1.34e-05	0.000341	CcSEcCtD
Idarubicin—Decreased appetite—Epirubicin—pancreatic cancer	1.32e-05	0.000336	CcSEcCtD
Idarubicin—Gastrointestinal pain—Epirubicin—pancreatic cancer	1.24e-05	0.000316	CcSEcCtD
Idarubicin—Decreased appetite—Doxorubicin—pancreatic cancer	1.22e-05	0.000311	CcSEcCtD
Idarubicin—Urticaria—Epirubicin—pancreatic cancer	1.2e-05	0.000307	CcSEcCtD
Idarubicin—Abdominal pain—Epirubicin—pancreatic cancer	1.2e-05	0.000306	CcSEcCtD
Idarubicin—Body temperature increased—Epirubicin—pancreatic cancer	1.2e-05	0.000306	CcSEcCtD
Idarubicin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	1.15e-05	0.000293	CcSEcCtD
Idarubicin—Hypersensitivity—Epirubicin—pancreatic cancer	1.12e-05	0.000285	CcSEcCtD
Idarubicin—Urticaria—Doxorubicin—pancreatic cancer	1.11e-05	0.000284	CcSEcCtD
Idarubicin—Body temperature increased—Doxorubicin—pancreatic cancer	1.11e-05	0.000283	CcSEcCtD
Idarubicin—Abdominal pain—Doxorubicin—pancreatic cancer	1.11e-05	0.000283	CcSEcCtD
Idarubicin—Diarrhoea—Epirubicin—pancreatic cancer	1.04e-05	0.000265	CcSEcCtD
Idarubicin—Hypersensitivity—Doxorubicin—pancreatic cancer	1.03e-05	0.000264	CcSEcCtD
Idarubicin—Vomiting—Epirubicin—pancreatic cancer	9.64e-06	0.000246	CcSEcCtD
Idarubicin—Diarrhoea—Doxorubicin—pancreatic cancer	9.6e-06	0.000245	CcSEcCtD
Idarubicin—Rash—Epirubicin—pancreatic cancer	9.56e-06	0.000244	CcSEcCtD
Idarubicin—Dermatitis—Epirubicin—pancreatic cancer	9.55e-06	0.000244	CcSEcCtD
Idarubicin—Headache—Epirubicin—pancreatic cancer	9.5e-06	0.000242	CcSEcCtD
Idarubicin—Nausea—Epirubicin—pancreatic cancer	9.01e-06	0.00023	CcSEcCtD
Idarubicin—Vomiting—Doxorubicin—pancreatic cancer	8.92e-06	0.000228	CcSEcCtD
Idarubicin—Rash—Doxorubicin—pancreatic cancer	8.85e-06	0.000226	CcSEcCtD
Idarubicin—Dermatitis—Doxorubicin—pancreatic cancer	8.84e-06	0.000226	CcSEcCtD
Idarubicin—Headache—Doxorubicin—pancreatic cancer	8.79e-06	0.000224	CcSEcCtD
Idarubicin—Nausea—Doxorubicin—pancreatic cancer	8.33e-06	0.000213	CcSEcCtD
